Brief Your CEO: The New Anti-Kickback Safe Harbors & Their Impact on Your Lab

If, like many lab managers, you are preparing to brief your CEO on significant regulatory changes from 2016 that are likely to impact business in 2017, be sure that the finalized revisions to the … [Read more...]


OIG Says No to Lab Providing Free Labeling Services to Dialysis Facility

Reiterating its longstanding aversion to labs providing free items or services to referral sources, the Department of Health & Human Services Office of Inspector General (OIG) issued an Advisory … [Read more...]


3 Things You Need to Know about the Lab Fee Schedule

The Centers for Medicare and Medicaid Services (CMS) issued the final 2017 Clinical Laboratory Fee Schedule (CLFS) on Nov. 21. Here is a look at the three key changes you need to know about going into … [Read more...]


Crosswalked Codes in 2017 Clinical Laboratory Fee Schedule

CPT Code Crosswalked To 80305 (Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures, (e.g., immunoassay) capable of being read by direct optical … [Read more...]


FDA Puts Final LDT Guidance on Ice—Agency Decides to Wait for Trump Administration

Whether you dreaded it or craved it, you will not be getting it—at least not any time soon. In the wake of the election, the U.S. Food and Drug Administration (FDA) let it be known that it will not … [Read more...]


2017 Medicare Lab Payments: The 9 Changes that May Affect Your Reimbursements

As the clock ticks down to 2018 and the new Protecting Access to Medicare Act of 2014 (PAMA) system for lab payments, the Centers for Medicare and Medicaid Services (CMS) issued final Medicare payment … [Read more...]


Brief Your CEO: Use New OIG Work Plan to Keep Your Lab Compliant in 2017

As the year comes to a close, lab managers need to brief their officers on the federal government enforcement initiatives that may affect operations in the coming year. The best place to turn for … [Read more...]


What Happens Next: Is a Trump Presidency Really the End for ACA?

Obamacare and the Affordable Care Act (ACA) are challenges you have been wrestling with for years. Now that Donald Trump has been elected president, was it all for naught? The short answer: No. While … [Read more...]


Quest Diagnostics Unveils a Pair of Personalized Medicine Blockbusters

Public support for personalized and precision medicine (PM) is running ahead of the health care industry's plans to develop and implement PM-based clinical strategies. At least that is the … [Read more...]


Is the Alere Dispute Hurting Abbott’s Strategic Position?

As the battle over the $5.8 billion Alere merger enters a new and nastier stage, there are indications that the conflict may be harming Abbott's strategic standing and ability to do other M&A … [Read more...]